Abstract:Background and aims Endoscopic full-thickness resection (EFTR) has been increasingly applied in the treatment of gastric submucosal tumors (G-SMTs) with explorative intention. This study aimed to compare the efficacy, tolerability, and clinical outcomes of EFTR and surgical intervention for the management of muscularis propria (MP)-derived G-SMTs. Methods Between September 2011 and May 2019, the clinical records of patients with MP-derived G-SMTs undergoing EFTR at our endoscopic unit were collected. A cohort of people with primary MP-derived G-SMTs treated by surgery was matched in a 1:1 ratio to EFTR group with regard to patients’ baseline characteristics, clinicopathologic features of the tumor and the procedure date. The perioperative outcomes and follow-up data were analyzed. Results In total, 62 and 62 patients were enrolled into the surgery and EFTR group, respectively, with median follow-up of 786 days. The size of G-SMTs (with ulceration) ranged from 10 to 90 mm. For patients with tumor smaller than 30 mm, surgery and EFTR group presented comparable procedural success rate (both were 100%), en bloc resection rate (100% vs. 94.7%), tumor capsule rupture rate (0% vs. 5.3%), and pathological R0 resection rate (both were 100%). EFTR had a statistically significant advantage over surgery for estimated blood loss (3.12 ± 5.20 vs. 46.97 ± 60.73 ml, p ≤ 0.001), discrepancy between the pre- and postprocedural hemoglobin level (5.18 ± 5.43 vs. 9.84 ± 8.25 g/L, p = 0.005), bowel function restoration [1 (0–5) vs. 3 (1–5) days, p ≤ 0.001], and hospital cost (28,617.09 ± 6720.78 vs. 33,963.10 ± 13,454.52 Yuan, p = 0.033). The patients with tumor larger than 30 mm showed roughly the same outcomes after comparison analysis of the two groups. However, the clinical data revealed lower en bloc resection rate (75.0% vs. 100%, p = 0.022) and higher tumor capsule rupture rate (25.0% vs. 0%, p = 0.022) for EFTR when compared to surgery. The procedure time, duration of postprocedural fasting and antibiotics usage, and hospital stay of the two groups were equivalent. The occurrence rate of adverse events within postoperative day 7 were 74.2% and 72.6% after EFTR and surgery, respectively ( p = 1.000). No complications occurred during the follow-up. Conclusion For treatment of MP-derived G-SMTs (with or without ulceration), our study showed the feasibility and safety of EFTR, which also provided better results in terms of procedural blood loss, the postoperative bowel function restoration and cost-effectiveness when compared to surgery, whereas the surgery was superior in en bloc resection rate for G-SMTs larger than 30 mm. The postprocedural clinical outcomes seemed to be equivalent in these two resection methods.

Endoscopic Resection Of Upper Gastrointestinal Subepithelial Tumors: Promising New Endoscopic Techniques-Are They Here To Stay?

Clinical analysis of endoscopic resection for submucosal tumors in the esophagogastric junction

Endoscopic Submucosal Dissection for the Treatment of Large Gastric Submucosal Tumors Originating from the Muscularis Propria Layer: a Single Center Study.

Resection of the Gastric Submucosal Tumor (G-SMT) Originating from the Muscularis Propria Layer: Comparison of Efficacy, Patients' Tolerability, and Clinical Outcomes Between Endoscopic Full-Thickness Resection and Surgical Resection

Progress of Upper Gastrointestinal Submucosal Tumors in Endoscopic Diagnosis and Treatment

Submucosal Tunneling Endoscopic Resection: a New Technique for Treating Upper GI Submucosal Tumors Originating from the Muscularis Propria Layer (with Videos)

Endoscopic full-thickness resection of colonic submucosal tumors originating from the muscularis propria: an evolving therapeutic strategy.

Submucosal Tunnel Endoscopic Resection for Extraluminal Tumors: a Novel Endoscopic Method for En Bloc Resection of Predominant Extraluminal Growing Subepithelial Tumors or Extra-Gastrointestinal Tumors (with Videos)

Effects Analysis of Endoscopic Submucosal Tunnel Dissection in Treatment of Upper Gastrointestinal Tumor

Sa1407 Submucosal Tunneling Endoscopic Resection for Upper-GI Submucosal Tumors: a Feasibility Study of 152 Consecutive Cases

Endoscopic transmural route for dissection of gastric submucosal tumors with extraluminal growth: experience in two cases

Endoscopic Treatment of Subepithelial Lesions of the Gastrointestinal Tract

Feasibility and safety of endoscopic full‐thickness resection for submucosal tumors in the upper gastrointestinal tract, including predominantly extraluminal submucosal tumors (with video)

453 Submucosal Tunneling Endoscopic Resection for Submucosal Tumors in Upper Gastrointestinal Tract: a Feasibility Study of 290 Consecutive Cases

Long-term Outcomes of Submucosal Tunneling Endoscopic Resection for Upper Gastrointestinal Submucosal Tumors

Endoscopic Resection of Upper Gastrointestinal Extraluminal Tumors

Endoscopic Resection of Upper GI Extraluminal Tumors (with Videos)

Current Status of Endoscopic Resection of Gastric Subepithelial Tumors.

[Selection and Evaluation of Endoscopic Resection for Submucosal Tumors of the Esophagogastric Junction Originating from Muscularis Propria].

Endoscopic Full‐thickness Resection for Gastrointestinal Submucosal Tumors

Management of the complications of submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors